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Abstract
As the number of submissions to Pilot and Feasibility Studies increases, there is a need for good quality reporting
guidelines to help researchers tailor their reports in a way that is consistent and helpful to other readers. The
publication in 2016 of the CONSORT extension to pilot and feasibility trials filled a much-needed gap, but there still
remains some uncertainty as to how to report pilot and feasibility studies that are not randomised. This editorial
aims to provide some general guidance on how to report the most common types of non-randomised pilot and
feasibility studies that are submitted to the journal. We recommend using the CONSORT extension to pilot and
feasibility trials as the main reference document—it includes detailed elaboration and explanation of each item,
and in most cases, simple adaptation, or non-use of items that are not applicable, will suffice. Several checklists
found on the Equator website may provide helpful supplementary guidance, when used alongside the CONSORT
extension, and we give some examples.
Introduction
Since the inception of the BMC journal Pilot and Feasibility
Studies in 2015 [1], the number of published studies has
risen sharply each year, totalling 379 by the end of 2018. In
2016, the Consolidated Standards of Reporting Trials
(CONSORT) extension to randomised pilot and feasibility
trials and two related methodology papers were published
by the Pilot and Feasibility Studies (PAFS) Working Group
(see the “Acknowledgements” section) to aid researchers in
the planning and reporting of these types of studies [2–5].
An associated PAFS website was created as a point of refer-
ence for information about pilot and feasibility studies and
associated events (https://pilotandfeasibilitystudies.qmul.ac.
uk/). Recently, we also published an editorial guide to the
reporting of protocols of randomised pilot and feasibility
trials [6], recommending the use of the CONSORT ex-
tension guideline [2, 3] alongside the SPIRIT (Standard
Protocol Items: Recommendations for Interventional
Trials) checklist [7].
These publications have focused on guidelines for
reporting randomised pilot and feasibility trials, but as
the number of manuscript submissions to the journal
continues to increase (by 200% from 2015 to 2018),
there has arisen a need for some guidance on the report-
ing of non-randomised pilot and feasibility studies. Many
non-randomised studies are undertaken before a rando-
mised pilot or feasibility trial takes place and may com-
prise a wide spectrum of study designs. In this editorial,
we discuss the most common types of non-randomised
studies seen in the journal and give guidance on how
they should be reported. In most cases, we recommend
referring to the CONSORT extension to pilot and feasi-
bility trials [2, 3] as many of the items (excluding items
that are specific to the randomisation nature of the
study) will be relevant for reporting other types of pilot
and feasibility studies, and the guideline provides helpful
examples and commentary for each of the 26 items.
Many other guidelines exist on the Equator (Enhancing
the QUAlity and Transparency Of health Research) web-
site (http://www.equator-network.org/), and with minor
amendments, some can be adapted for reporting certain
types of non-randomised studies.
This editorial is based on our experience of submis-
sions to the journal over the past 4 years, and while it
does not provide comprehensive coverage of all types of
non-randomised pilot and feasibility studies, it will hope-
fully provide some useful suggestions and signposts to
relevant guidance and examples as an aid to reporting
these studies. A point to note here is that our work to
date has shown that there is a lack of consensus over the
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usage of the words ‘pilot’ and ‘feasibility’ [4], and so as a
consequence, both terms are currently being used inter-
changeably in the journal.
Guidance for reporting non-randomised pilot and
feasibility studies for submission to the journal
In the journal Pilot and Feasibility Studies, aided by the
CONSORT extension to pilot and feasibility trials, authors
are encouraged to report the purpose of a feasibility or
pilot study in the context of the planned future study.
Many types of non-randomised feasibility studies are at an
earlier stage of preparation to that of a randomised pilot
or feasibility trial. The proposed methodology and proce-
dures for the main randomised controlled trial (RCT) may
still be under development and not yet ready to fully pilot
test. These studies usually focus on one or more related
but substantive areas of development along the RCT pre-
paratory pathway (e.g. intervention development, develop-
ment of patient-reported outcome measures (PROMS),
piloting of several components of the main trial and pilot-
ing the feasibility of implementation).
Moreover, not all pilot and feasibility studies relate to
trials or interventional studies; some concern testing out
design features of future large-scale cohort studies, such
as the feasibility of roll-out across a wide area or being
able to obtain buy-in from different stakeholders. Other
researchers may want to test the feasibility of prelimin-
ary hypotheses of associations between variables that
may be important to inform future research before any
kind of intervention is developed or future study planned.
Table 1 lists the main types of non-randomised feasibil-
ity studies seen in the journal, and we provide guidance
and examples for reference.
Intervention development
Studies that describe intervention development typically
adopt mainly qualitative methods. The Template for Inter-
vention Description and Replication (TIDieR) guideline
exists for reporting intervention description [8]. Interven-
tion development studies often describe a theoretical model
that underpins the reasoning behind the intervention and
through literature review or focus group work develop a
feasible intervention model. This new intervention is then
tried out on a small number of patients and adopted or
modified as necessary.
The first thematic series of the journal covered inter-
vention development and drew upon the expertise of
guest editor, Professor Pat Hoddinott, to oversee the
papers contributing to the series. Around the same time,
Professor Alicia O’Cathain and colleagues published a
guidance paper on maximising the impact of qualitative
research in feasibility studies for RCTs (a highly accessed
article) [9]. Hand in hand with the nine papers in the
thematic series, these provide a good set of examples
covering issues of complex intervention development
[10–12] and strategic optimisation [13], a person-based
approach to enhancing acceptability [14], intervention
mapping [15] and obtaining clinical collaboration
through a Knowledge to Action framework [16].
Development of PROMs
PROM development, or development of any questionnaire-
based outcome measure, has some methodological similar-
ities to the previous section in terms of selection of the
proposed items for the PROM. Items generally stem from
an underlying theoretical model and literature review, aided
by focus group work with some preliminary testing. The
PROM is then assessed for its preliminary reliability and
validity in certain patient populations related to its intended
use. In our second thematic series of the journal, guest edi-
tor, Professor Georgina Jones, presents seven papers that
represent the types of pilot work that might take place in
PROM development, including issues of translation and
back-translation for use in another language [17], time and
cost of administration [18], technology-based assessment
[19] and the use of e-PROMS [20]. In another study, the
authors follow the RE-AIM (Reach, Effectiveness, Adoption,
Implementation, Maintenance) framework [21] to pilot and
evaluate use at clinic of an adolescent needs assessment tool
for type 1 diabetes [22].
The CONSORT Patient-Reported Outcomes (PRO)
guideline for the reporting of PROMs in main RCTs [23]
may provide some further help but it should be adapted in
line with the CONSORT extension to pilot and feasibility
trials. The COSMIN (COnsensus-based Standards for the
selection of health Measurement INstruments) guideline
for systematic reviews of PROMs [24] is a comprehensive
document to also be aware of especially when reporting
aspects of preliminary reliability and validity and when
considering the design of a future large-scale validation
study.
Piloting several components of the trial
Quite often enough may be known about the study
design (e.g. from conducting previous trials in the same
area) to not warrant a fully randomised pilot or feasibil-
ity trial. But it may still be necessary to try out certain
aspects of the intervention delivery to ensure it will
work. Generally, either a before-after study design test-
ing out processes related to the intervention arm only,
or processes related to the delivery of both arms without
randomisation will suffice. In these cases, we would still
recommend using the CONSORT extension to pilot and
feasibility trials, as it can usually be readily adapted to
these situations. Any items not applicable, for example,
items 8a–10 about randomisation, can be ignored in a
before-after single-arm study or adapted to non-random
allocation for a two-arm non-randomised study.
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Table 1 Main types of non-randomised feasibility studies submitted to the journal, where to find guidance and published examples
Type of study Equator website checklists
and other helpful guidance
Published examples
Intervention development TIDieR
http://www.equator-network.org/reporting-
guidelines/tidier/
Maximising the impact of qualitative research
in feasibility studies for randomised controlled
trials: guidance for researchers (O’Cathain et al):
https://pilotfeasibilitystudies.biomedcentral.
com/articles/10.1186/s40814-015-0026-y
Thematic series on intervention
development available at:
https://www.biomedcentral.com/collections/
interventiondevelopment
Patient-Reported Outcome
Measures (PROMS) development
CONSORT PRO (adapt alongside CONSORT
extension to pilot trials)
http://www.equator-network.org/reporting-
guidelines/consort-pro/
COSMIN User Manual (comprehensive
reference, useful risk of bias tool)
https://cosmin.nl/wp-content/uploads/
COSMIN-syst-review-for-PROMs-manual_
version-1_feb-2018.pdf
Thematic series on pilot and feasibility testing of
patient-reported outcome measures available at:
https://www.biomedcentral.com/collections/
pilotfeasibilityPROMs
Piloting several components
of the trial
CONSORT extension to pilot trials (ignoring
items not applicable)
http://www.equator-network.org/reporting-
guidelines/consort-2010-statement-extension-
to-randomised-pilot-and-feasibility-trials/
Aging, Community and Health—Community
Partnership Program before-after study [25]:
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-016-0063-1
POWeR-RN non-randomised study with
wait-list control [26]
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-017-0122-2#Sec16
Implementation of research findings CONSORT extension to pilot trials (ignoring
items not applicable)
http://www.equator-network.org/reporting-
guidelines/consort-2010-statement-extension-
to-randomised-pilot-and-feasibility-trials/
RE-AIM (Reach, Effectiveness, Adoption,
Implementation, Maintenance) framework for
evaluating interventions
http://www.re-aim.org/
Please note that when applying RE-AIM to
pilot and feasibility studies, ‘potential effective-
ness’ only should be addressed.
Thematic series on implementation science and
practice forthcoming at:
https://www.biomedcentral.com/collections/
implementationscience-pilotstudies
GLA:D® Back before-after study [28]:
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-019-0448-z
GenerationPMTO before-after study [29]
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-019-0476-8
Feasibility studies in preparation
for a cohort or other large scale study
STROBE (ignoring items not applicable)
http://www.equator-network.org/reporting-
guidelines/strobe/
CONSORT extension to pilot trials (ignoring
items not applicable)
http://www.equator-network.org/reporting-
guidelines/consort-2010-statement-extension-
to-randomised-pilot-and-feasibility-trials/
• Ensure there is adequate explanation as to
why the study is a feasibility study, and state
clear feasibility objectives
• Ensure a formal sample size calculation is
reported if hypothesis testing is carried out
Community-based paediatric respiratory
infection surveillance cohort study [31]:
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-018-0371-8
Prognosis of patients with apparent treatment-
resistant hypertension [32]:
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-018-0232-5
Feasibility studies that test preliminary
hypotheses of association
STROBE (ignoring items not applicable)
http://www.equator-network.org/reporting-
guidelines/strobe/
CONSORT extension to pilot trials (ignoring
items not applicable)
http://www.equator-network.org/reporting-
guidelines/consort-2010-statement-extension-
to-randomised-pilot-and-feasibility-trials/
• Ensure there is adequate explanation as to
why the study is a feasibility study, and state
clear feasibility objectives
• Ensure a formal sample size calculation is
reported if hypothesis testing is carried out
Is cognitive function in delirium associated with
EEG frequency band connectivity
(case-control study) [33]?
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-018-0388-z
Are foetus mouth movements associated with
sound stimulation in the womb [34]?
https://pilotfeasibilitystudies.biomedcentral.com/
articles/10.1186/s40814-016-0053-3
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One example of a before-after study examines the
feasibility of the Aging, Community and Health—Com-
munity Partnership Program, an inter-professional, nurse-
led programme to promote diabetes self-management in
older adults with type 2 diabetes and multiple chronic
conditions [25]. A non-randomised study example adopts
the RE-AIM framework [21] to assess the feasibility of
implementing a modified weight loss programme, Positive
Online Weight Reduction for Royal Navy (POWeR-RN),
in overweight and obese navy personnel with a wait-list
control group [26].
Piloting the feasibility of implementation of research
findings
Implementation of methods to promote the systematic
uptake of research findings, including interventions and
other evidence-based practices into routine practice, is
the topic of our third thematic series—currently an open
call. Piloting plans for future implementation and evalu-
ation of research programmes and showing them to be
feasible is an important part of implementation research
on the continuum of getting research into current prac-
tice. While there are journals focussing on implementa-
tion research, the preparation that goes into these
programmes is not always apparent or well-reported.
Again, we would recommend using the CONSORT
extension to pilot and feasibility trials as the basis for
reporting such studies with suitable adaptation of items
where necessary. The one published paper from the call
to date describes the implementation into nutritional
rehabilitation units in Malawi of the Kusamala Program,
an interactive counselling programme for primary care-
givers of children with severe acute malnutrition [27]. In
the GLA:D® Back (Good Life with osteoArthritis in
Denmark) before-after study, physiotherapists and chiro-
practors were trained in intervention delivery of standar-
dised care following national guidelines for low back
pain to plan a future implementation-effectiveness study
[28]. Another example seeks to improve the implementa-
tion of evidence-based practices by teaching the Generation
Parent Management Training Oregon (GenerationPMTO®)
model, a parenting intervention, in a university graduate
curriculum [29]. The RE-AIM framework has also been
used in this context [21, 22].
Feasibility studies in preparation for a cohort or other
large scale study
While the majority of studies submitted to the journal
are in preparation for a main future RCT, the journal is
also open to submission of articles related to pilot and
feasibility work for cohort studies or other large-scale
observational studies. The STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology)
guideline [30] provides a checklist of items that should
be included in these types of reports, and most items are
applicable to pilot and feasibility studies. However, care
should be taken to state clearly the aims and feasibility
objectives for the pilot work which should differ from
those of the main future study. For this reason, it is
recommended that the STROBE checklist is used along-
side the CONSORT extension to pilot and feasibility
trials to ensure that all items relate or are adapted to
issues of feasibility.
Examples of feasibility cohort studies that have been
published in the journal to date have concerned the
feasibility of recruiting and following up children with
respiratory tract infections in the community, including
collecting microbiological, symptom severity and duration
data [31], and determining the feasibility of recruiting
practices and patients with apparent treatment-resistant
hypertension for data collection and follow-up of out-
comes [32].
Feasibility studies that test preliminary hypotheses of
association
Sometimes, it is necessary to test preliminary hypotheses
of associations between variables which if found to be
promising may lead to intervention development or
other preliminary work. In other cases, the associations
may be in preparation for a trial. These studies are in
the minority in the journal, but there are several exam-
ples to draw upon. Some adopt observational study
designs and some are non-randomised experiments. We
again recommend the use of the STROBE guideline
alongside the CONSORT extension to pilot and feasibil-
ity trials with suitable adaptation of items as necessary.
The two examples in Table 1 look at associations
between delirium and electroencephalography (EEG) fre-
quency band connectivity readings as potential future
therapeutic and diagnostic biomarkers [33] and whether
sound stimulation in the womb is associated with mouth
movements in the foetus [34]. If these associations are
observed, then further future research can be planned.
Discussion
We have provided guidance for reporting non-randomised
pilot and feasibility studies. In most cases, existing guide-
lines can be adapted and utilised for this purpose, and we
have taken some sample guidelines from the Equator
website. While we have categorised studies into several
common types, as can be seen from the published exam-
ples, there is overlap in the types of studies discussed with
some examples fitting under more than one sub-heading.
In this editorial, we have taken all examples from the
journal Pilot and Feasibility Studies. Many journals still
do not have a policy of publishing pilot and feasibility
studies. In a previous review of four subject-specific
journals and three general mainstream medical journals,
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Lancaster et al. [35] identified only 90/4449 (2%) re-
search studies published between 2000 and 2001 that
called themselves ‘pilot’ or ‘feasibility’ studies. The
majority were studies piloting a new treatment or
technique (70%), piloting guidelines (11%), or screen-
ing programmes (5%). Surprisingly at the time, only
4 out of the 90 pilot/feasibility studies across all 7
journals were identified as being in preparation for a
future RCT. Today, with the publication of the CON-
SORT extension to pilot and feasibility trials in 2016
[2, 3] and aided by other influential papers [36, 37],
this number has improved, and we are starting to see
phases of pilot and feasibility work published along
the RCT preparatory pathway.
Most research submitted to the journal reports on one
substantive phase of work at a time, addressing interven-
tion development work or uncertainties in the study de-
sign. Research protocol submissions may describe the
substantive preparatory phases altogether in one publica-
tion as a set of planned sub-studies, for example, theor-
etical review, intervention development and testing (in a
few patients), feasibility testing in a larger patient sam-
ple, feasibility of implementation into practice and ac-
ceptability to key stakeholders. Problems can arise when
researchers attempt to report multiple results from each
phase within one paper, and this poses a risk of underre-
porting all of the pertinent findings.
The publication and sharing of detailed feasibility work
has many benefits for researchers across disciplines in
learning from each other, in reusing techniques that
have proved successful and in avoiding similar pitfalls.
Much preparatory and exploratory work is linked to the
development and evaluation of complex interventions
and as such should comply with the UK Medical Re-
search Council (MRC) guidance [38]. This guidance is
currently being updated, and we welcome mention of
the progress that has been made to date in providing a
more comprehensive framework for reporting pilot and
feasibility studies [2–4].
Conclusion
We hope that this editorial will be helpful to researchers
when reporting non-randomised feasibility and pilot
studies. We recommend that authors use the current
guidance available and ensure items are included to em-
phasise the goal of feasibility, such as specific feasibility
objectives, feasibility outcomes and progression cri-
teria. In writing this guidance, we have tried to identify
and clarify the main kinds of issues we repeatedly see in
our roles as Editors-in-Chief in an attempt to help
researchers in reporting their work. We would like to
end by re-iterating the message that reporting guideline
publications that contain explanation and elaboration
commentary on each item are very useful reference doc-
uments to consult not only at the end of a study when
writing up the results, but also at the planning stage of a
study when constructing an appropriate study design.
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